1. Home
  2. AAPG vs NSIT Comparison

AAPG vs NSIT Comparison

Compare AAPG & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • NSIT
  • Stock Information
  • Founded
  • AAPG 2009
  • NSIT 1988
  • Country
  • AAPG China
  • NSIT United States
  • Employees
  • AAPG N/A
  • NSIT N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • NSIT EDP Services
  • Sector
  • AAPG Health Care
  • NSIT Technology
  • Exchange
  • AAPG Nasdaq
  • NSIT Nasdaq
  • Market Cap
  • AAPG 3.6B
  • NSIT 2.8B
  • IPO Year
  • AAPG 2025
  • NSIT 1995
  • Fundamental
  • Price
  • AAPG $34.30
  • NSIT $88.98
  • Analyst Decision
  • AAPG Strong Buy
  • NSIT Buy
  • Analyst Count
  • AAPG 3
  • NSIT 3
  • Target Price
  • AAPG $49.00
  • NSIT $168.33
  • AVG Volume (30 Days)
  • AAPG 8.1K
  • NSIT 482.6K
  • Earning Date
  • AAPG 11-19-2025
  • NSIT 10-30-2025
  • Dividend Yield
  • AAPG N/A
  • NSIT N/A
  • EPS Growth
  • AAPG N/A
  • NSIT N/A
  • EPS
  • AAPG N/A
  • NSIT 4.21
  • Revenue
  • AAPG $54,524,554.00
  • NSIT $8,271,548,000.00
  • Revenue This Year
  • AAPG N/A
  • NSIT N/A
  • Revenue Next Year
  • AAPG $368.64
  • NSIT $3.42
  • P/E Ratio
  • AAPG N/A
  • NSIT $21.03
  • Revenue Growth
  • AAPG N/A
  • NSIT N/A
  • 52 Week Low
  • AAPG $16.50
  • NSIT $87.63
  • 52 Week High
  • AAPG $48.45
  • NSIT $181.92
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • NSIT 19.91
  • Support Level
  • AAPG $30.93
  • NSIT $89.57
  • Resistance Level
  • AAPG $34.31
  • NSIT $92.82
  • Average True Range (ATR)
  • AAPG 0.81
  • NSIT 3.33
  • MACD
  • AAPG 0.26
  • NSIT -0.31
  • Stochastic Oscillator
  • AAPG 85.99
  • NSIT 8.39

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About NSIT Insight Enterprises Inc.

Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.

Share on Social Networks: